BEIJING, CHINA/ SINGAPORE: NovogeneAIT Genomics Singapore (NovogeneAIT) and Genome Institute of Singapore (GIS) said that it will establish a joint whole genome sequencing (WGS) centre at Biopolis, Singapore.
NovogeneAIT is a joint venture between Novogen, a leading provider of genomic services and solutions with cutting-edge next-generation sequencing and bioinformatics expertise; and AITbiotech Pte Ltd, a Singapore biotechnology company.
The new centre will provide Illumina HiSeq X based whole genome sequencing and bioinformatics analysis of human, plant and animal samples for biomedical and agricultural researchers. The centre will offer a major portion of its sequencing capability to support public research projects and empower super scale sequencing initiatives in Singapore and the region.
Additionally, NovogeneAIT will collaborate with GIS to develop new applications of next-generation sequencing, such as WGS solutions for cancer diagnosis and stratified cancer treatment.
“I am very excited and pleased to announce this significant new initiative with the Genome Institute of Singapore,” stated Dr Ruiqiang Li, CEO of Novogene.
“The centre is the first major project for NovogeneAIT and is an important milestone for our company. We look forward to providing high-quality sequencing services in Singapore and to advancing important research initiatives that can benefit humanity,” added Dr Ruiqiang.
“We are delighted to work with a local biotech company. Such public-private partnerships will prove to be highly beneficial as it leverages the strengths of both parties to advance genomic science and medicine in Singapore, as well as to create successful local biotech companies,” said prof Ng Huck Hui, executive director of GIS.
Read More: NovogeneAIT, GIS to establish whole genome sequencing centre in Singapore
No comments:
Post a Comment